ATE49209T1 - Phenylnaphthyridine, verfahren zu deren herstellung, diese enthaltende arzneimittel, insbesondere antigeschwuer. - Google Patents

Phenylnaphthyridine, verfahren zu deren herstellung, diese enthaltende arzneimittel, insbesondere antigeschwuer.

Info

Publication number
ATE49209T1
ATE49209T1 AT85401342T AT85401342T ATE49209T1 AT E49209 T1 ATE49209 T1 AT E49209T1 AT 85401342 T AT85401342 T AT 85401342T AT 85401342 T AT85401342 T AT 85401342T AT E49209 T1 ATE49209 T1 AT E49209T1
Authority
AT
Austria
Prior art keywords
ulculator
phenylnaphthyridine
manufacture
especially anti
medications containing
Prior art date
Application number
AT85401342T
Other languages
English (en)
Inventor
Jean-Marie Teulon
Original Assignee
Union Pharma Scient Appl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union Pharma Scient Appl filed Critical Union Pharma Scient Appl
Application granted granted Critical
Publication of ATE49209T1 publication Critical patent/ATE49209T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT85401342T 1984-07-11 1985-07-03 Phenylnaphthyridine, verfahren zu deren herstellung, diese enthaltende arzneimittel, insbesondere antigeschwuer. ATE49209T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8411040A FR2567520B1 (fr) 1984-07-11 1984-07-11 Nouvelles phenyl-naphthyridines, leur procede de preparation, medicaments les contenant, notamment anti-ulceres
EP85401342A EP0172058B1 (de) 1984-07-11 1985-07-03 Phenylnaphthyridine, Verfahren zu deren Herstellung, diese enthaltende Arzneimittel, insbesondere Antigeschwür

Publications (1)

Publication Number Publication Date
ATE49209T1 true ATE49209T1 (de) 1990-01-15

Family

ID=9306028

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85401342T ATE49209T1 (de) 1984-07-11 1985-07-03 Phenylnaphthyridine, verfahren zu deren herstellung, diese enthaltende arzneimittel, insbesondere antigeschwuer.

Country Status (15)

Country Link
US (1) US4622328A (de)
EP (1) EP0172058B1 (de)
JP (1) JPS6140287A (de)
KR (1) KR900004828B1 (de)
AT (1) ATE49209T1 (de)
AU (1) AU578295B2 (de)
DE (1) DE3575139D1 (de)
DK (1) DK306385A (de)
ES (1) ES8609319A1 (de)
FR (1) FR2567520B1 (de)
GR (1) GR851657B (de)
NZ (1) NZ212658A (de)
PH (1) PH21165A (de)
PT (1) PT80791B (de)
ZA (1) ZA855124B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ218774A (en) * 1986-01-06 1990-06-26 Carpibem 3-substituted phenylnaphthyridines and pharmaceutical compositions
NZ218773A (en) * 1986-01-06 1990-05-28 Carpibem 3-methyl-2-oxo-1-(substituted phenyl)-naphthyridines and pharmaceutical compositions
US4775686A (en) * 1986-10-15 1988-10-04 Schering Corporation Naphthyridine derivatives and method for treating allergic reactions
EP0267691A3 (de) * 1986-10-15 1989-08-23 Schering Corporation Verwendung von 1-substituierten Naphthyridin- und Pyridopyrazinderivaten für die Herstellung von Immunosuppressoren-arzneimittel.
US4916131A (en) * 1986-10-15 1990-04-10 Schering Corporation Naphthyridine derivatives and method for treating allergic reactions
US5037826A (en) * 1986-10-15 1991-08-06 Schering Corporation 1-substituted naphthyridine and pyridopyrazine derivatives
US5760034A (en) * 1990-11-30 1998-06-02 Schering Corporation Heterocyclic substituted naphthyridinones and methods and compositions employing them
FR2706898B1 (de) * 1993-06-25 1995-09-08 Union Pharma Scient Appl
GB9622386D0 (en) * 1996-10-28 1997-01-08 Sandoz Ltd Organic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4128649A (en) * 1977-06-29 1978-12-05 Sandoz, Inc. 4-Hydroxy-pyrido[2,3-b]pyridine-2(1H)-one-3-carboxylic acids and esters
US4133885A (en) * 1977-07-18 1979-01-09 Merck & Co., Inc. Substituted naphthyridinones
US4324893A (en) * 1979-04-18 1982-04-13 American Home Products Corporation 4-Amino-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives
US4215123A (en) * 1979-05-07 1980-07-29 American Home Products Corporation Antisecretory 4-oxy-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives
EP0092786B1 (de) * 1982-04-26 1987-01-07 Schering Corporation 1,8-Naphthyridine- und 1,5,8-Azanaphthyridine-Derivate

Also Published As

Publication number Publication date
FR2567520A1 (fr) 1986-01-17
KR860001108A (ko) 1986-02-22
GR851657B (de) 1985-11-26
KR900004828B1 (ko) 1990-07-07
JPH0374668B2 (de) 1991-11-27
ES8609319A1 (es) 1986-07-16
NZ212658A (en) 1988-02-29
US4622328A (en) 1986-11-11
PT80791B (pt) 1987-09-18
DE3575139D1 (de) 1990-02-08
DK306385A (da) 1986-01-12
ES545009A0 (es) 1986-07-16
FR2567520B1 (fr) 1987-01-02
DK306385D0 (da) 1985-07-04
EP0172058A1 (de) 1986-02-19
EP0172058B1 (de) 1990-01-03
PT80791A (fr) 1985-08-01
AU578295B2 (en) 1988-10-20
AU4473185A (en) 1986-01-16
PH21165A (en) 1987-08-05
ZA855124B (en) 1986-01-29
JPS6140287A (ja) 1986-02-26

Similar Documents

Publication Publication Date Title
ATE60582T1 (de) Oxindol-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und zwischenprodukte.
DK142985D0 (da) Redox-indikatorer
ATE49209T1 (de) Phenylnaphthyridine, verfahren zu deren herstellung, diese enthaltende arzneimittel, insbesondere antigeschwuer.
ATE48137T1 (de) Neue benzodipyrrole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ATE42553T1 (de) Substituierte 5,11-dihydro-6h-dibenz(b,e)azepin-6-one, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ATE48835T1 (de) Chinolylglycinamidderivate, verfahren zu ihrer herstellung und therapeutische verwendung als psychotrope.
FI875596A (fi) Foerfarande foer framstaellning av tienyletylaminer och aeven ditienyletylaminer.
ATE66230T1 (de) Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ATE24902T1 (de) Substituierte (10h-phenothiazin-10-yl)propyl-1piperazin-derivate, verfahren zu deren herstellung sowie arzneimittel enthaltend diese verbindungen.
ES529223A0 (es) Un procedimiento de preparacion de imino-2-pirrolidinas.
ATE43341T1 (de) Hexakoordinierte siliciumkomplexe, verfahren zu deren herstellung und deren verwendung.
OA07301A (fr) Procédé pour la préparation d'acyl-2 hexahydro-1, 2, 3, 4, 6, 7, 11b-2h pyrazino (2,1-a) isoquinolène-4 et intermediaires.
ATE38515T1 (de) Spiro-2-aza-alkan-3-carbonitrile, verfahren zu ihrer herstellung und ihre verwendung.
AU8879482A (en) 4-acylamino-1-aza-adamantanes
PT71313A (de) Verfahren zu herstellung neue guanidinderivate
PT80759A (de) Neue imidazolylverbindungen verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
PT81702B (de) N-substituierte aziridin-2-carbonsauerederivate verfahren zu deren herstellung sowie diese substanzen enthaltende arzneimittel
DE3671444D1 (de) Biologisch aktive substanz, girolline genannt, extrahiert aus dem schwamm pseudaxinyssa cantharella, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE33837T1 (de) Azolylmethylcycloacetale, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE7298T1 (de) Basisch substituierte 5-phenyltetrazole, verfahren zu ihrer herstellung und ihre verwendung als heilmittel.
ATE7901T1 (de) Neue antibiotisch wirksame verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.
ATE5318T1 (de) 4-niedrig-hydrocarbyl-3-phenoxypyridin-1-oxide, verfahren zu ihrer herstellung, diese verbindungen enthaltende zusammensetzungen und ihre verwendung.
ATE25517T1 (de) Delta-1-pyrrolin-thiolactimaether und verfahren zu ihrer herstellung.
ATE18398T1 (de) Verfahren zur herstellung von (thio)hydantoinen.
ATE225T1 (de) Neue substituierte 2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee